B cells mediate chronic allograft rejection independently of antibody production

Journal of Clinical Investigation

Volumn 124, Issue 3, 2014, Pages 1052-1056

  Zeng, Qiang ^a,b   Ng, Yue Harn ^a,b,c   Singh, Tripti ^a,b   Jiang, Ke ^a,b,d   Sheriff, Khaleefathullah A ^a,b   Ippolito, Renee ^a,b   Zahalka, Salwa ^b   Li, Qi ^a,b   Randhawa, Parmjeet ^a,b   Hoffman, Rosemary A ^a,b   Ramaswami, Balathiripurasundari ^a,b   Lund, Frances E ^e   Chalasani, Geetha ^a,b,f  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e University of Alabama at Birmingham   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN M; IMMUNOGLOBULIN MU CHAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTERITIS; ARTICLE; B LYMPHOCYTE; CHRONIC ALLOGRAFT VASCULOPATHY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEART TRANSPLANTATION; HYPERPLASIA; IMMUNOGLOBULIN PRODUCING CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VASCULAR DISEASE;

ALLOGRAFTS; ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; GRAFT REJECTION; HEART TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYOCARDIUM; T-LYMPHOCYTES;

EID: 84896766660     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI70084     Document Type: Article

References (28)

1. Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant. 2011;11(6):1226-1235.
2. Radio S, Wood S, Wilson J, Lin H, Winters G, McManus B. Allograft vascular disease: comparison of heart and other grafted organs. Transplant Proc. 1996;28(1):496-499.
3. Mauiyyedi S, et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol. 2001;12(3):574-582.
4. Terasaki PI, Cai J. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation. 2008;86(3):377-383.
5. Nath DS, et al. Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation. Hum Immunol. 2010;71(12):1191-1196.
6. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol. 1994;152(10):5135-5141.
7. Uehara S, Chase CM, Cornell LD, Madsen JC, Russell PS, Colvin RB. Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant. 2007;7(1):57-65.
8. Sis B, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant. 2007;7(7):1743-1752.
9. Uehara S, et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol. 2005;175(5):3424-3430.
10. Kitchens WH, et al. Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant. 2007;7(12):2675-2682.
11. Suzuki J, et al. Tumor necrosis factor receptor-1 and-2 double deficiency reduces graft arterial disease in murine cardiac allografts. Am J Transplant. 2003;3(8):968-976.
12. Wang Y, et al. Interferon-γ plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. FASEB J. 2004;18(3):606-608.
13. Shi C, et al. Immunologic basis of transplantassociated arteriosclerosis. Proc Natl Acad Sci U S A. 1996;93(9):4051-4056.
14. Noorchashm H, et al. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol. 2006;177(11):7715-7722.
15. Ng YH, Oberbarnscheidt MH, Chandramoorthy HC, Hoffman R, Chalasani G. B cells help alloreactive T cells differentiate into memory T cells. Am J Transplant. 2010;10(9):1970-1980.
16. Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat Rev Immunol. 2010;10(4):236-247.
17. Nolte MA, et al. B cells are crucial for both development and maintenance of the splenic marginal zone. J Immunol. 2004;172(6):3620-3627.
18. Ngo VN, Cornall RJ, Cyster JG. Splenic T zone development is B cell dependent. J Exp Med. 2001;194(11):1649-1660.
19. Fu YX, Huang G, Wang Y, Chaplin DD. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med. 1998;187(7):1009-1018.
20. Chalasani G, et al. The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J Immunol. 2004;172(12):7813-7820.
21. Kumazaki K, Tirosh B, Maehr R, Boes M, Honjo T, Ploegh HL. AID-/-mus-/-mice are agammaglobulinemic and fail to maintain B220-CD138+ plasma cells. J Immunol. 2007;178(4):2192-2203.
22. Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature. 1991;350(6317):423-426.
23. Goodnow CC, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 1988;334(6184):676-682.
24. DiLillo DJ, et al. B lymphocytes differentially influence acute and chronic allograft rejection in mice. J Immunol. 2011;186(4):2643-2654.
25. Kelishadi SS, et al. Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys. J Clin Invest. 2010;120(4):1275-1284.
26. Liu C, et al. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med. 2007;13(11):1295-1298.
27. Looney RJ, et al. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum. 2004;50(8):2580-2589.
28. Ding Q, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest. 2011;121(9):3645-3656.